My account:




  remember me

Enter   Register
Information
All rights reserved. Any reprinting of materials of the site is possible only with the written permission of administration and with a direct hyperlink to this site.

Conferences



ISPOR 18th Annual European Congress
7-11 November 2015
Milan, Italy



Activities of the Russia HTA Chapter:

13 posters were presented;

ISPOR Russia HTA Chapter meeting
16:30 – 18:30, Monday, November 9, 2015
The topic of the Meeting: «Perspectives of development of HTA principles in Russia by the example of the Russian Federation Government decree ¹871».
Moderator: Vitaly V. Omelyanovskiy, MD, PhD, Professor, Director of Center of Healthcare Quality Assessment and Control of the Ministry of health of the Russian Federation Director of Center for HTA, Russian Presidential Academy of National Economy & Public Administration, President of ISPOR Russia HTA Chapter.
The event program is available in English.

Director of the ISPOR Russia HTA Chapter professor Vitaly Omelyanovskiy took part in following events:

ISPOR 18th Health Technology Assessment (HTA) Roundtable – EUROPE
08:00 – 18:00, Sunday, November 8, 2015

Forum: Multi-Criteria Decision Making in the Central & Eastern European (CEE) region: are we there yet?
17:45 – 18:45, Tuesday, November 10, 2015
Presented by the ISPOR CEE Network
Moderator:Zoltán Kaló, PhD, Professor of Health Economics, Department of Health Policy and Economics, Faculty of Social Sciences, Eötvös Loránd University, Budapest, Hungary

Workshop: Incorporating Equity into Health Technology Assessment: An Illustration and Critical Review of Good Practice
13:45 – 14:45, Wednesday, November 11, 2015
Vitaly Omelyanovskiy has presented some of the possible issues for MCDA usage within the Russian healthcare environment and illustrate the incorporation of equity into MCDA using the case study of the pilot of a MCDA to value orphan drugs in Russia.

2nd International scientific and practical conference «Health technology assessment: ways of development in Russia»:


Moscow, November 2, 2015

Nowadays health technology assessment (HTA), clinical and economical expertise are getting more support worldwide and in Russia, in particular. The amendments to the Federal law on medicines of the Russian Federation dated April 12, 2012, including introducement of the term of "comprehensive HTA", came into effect July 1, 2015. In order to comply with these amendments every medicine will have to go through the process of evaluation to be included in restrictive lists and receive a governmental funding. National Agency under the authority of the Ministry of Health of the Russian Federation responsible for HTA in the country – Center of Healthcare Quality Assessment and Control was created in 2015.
Considering the importance of these changes in context of perspectives of HTA system development the 2ndInternational scientific and practical Conference "Health technology assessment: ways of development in Russia" was held in Moscow, November 2, 2015.
The Conference was supported by the Ministry of Health of the Russian Federation, theMinistry of Finance of the Russian Federation,the Ministry of Industry and Trade of the Russian Federation, theCouncil of the Federation Committee on Social Policy of the Federal Assembly of the Russian Federation,Skolkovo Foundation,Center of Healthcare Quality Assessment and Control,Financial Research Institute of the Ministry of Health of the Russian Federation andInternational Society for Pharmacoeconomics and Outcomes Research.
The main topics of the Conference were international experience on developing HTA system and methodologicalaspects of HTA.
The Conference was attended by more than 450 participants – representatives of federal and regional legislative and executive authorities, heads of relevant regional ministries and agencies of the RF, representatives of the Federal and regional compulsory medical insurance funds, scientific expert community, staff members of RF medical institutions of higher education, representatives of the industry and insurance companies, leading specialists of European HTA agencies of the BRICS countries, the European network for health technology assessment (EUnetHTA) as well as local and international HTA and drug supply experts and mass media representatives.
One-day program of the Conference included Plenary Session(Establishment and development of HTA system in the Russian Federation)and thematic sessions dedicated to funding of healthcare in the RussianFederation and Determinants of development and drug provision regulation perspectives in the RussianFederation.
Following the Conference a number of proposals addressed to legislative and executive authorities have been formed. It has also been proposed to the Ministry of Health of the Russian Federation to develop a road map for introducing the HTA system into practice and into the educational program for the system of higher education. Based on the results of the Conference it has been decided to form a working group aimed at improving the HTA methods in Russia at the Center of Healthcare Quality Assessment and Control.
 

 
ISPOR 16th Annual European Congress

2-6 November 2013
Dublin, Ireland

Activities of the Russia HTA Chapter: 

14 posters were presented;
   

How can the Russian pharma industry benefit and leverage population and patient data with local authorities?

12:15 – 14:00, Monday, November 4, 2013
The discussion will focus on the role of patient reported outcomes (PRO), expectations of different HTA agencies (with focus on UK) and the benefits of preparing PRO data for the industry and state.
The meeting will be held in English.
Moderator: Mira Pavlovic, MD, Deputy Director for Health Technology Assessment, Haute Autorité de Santé (HAS), Saint-Denis La Plaine, France, EUnetHTA

New health reforms and HTA status in Russia, Ukraine, Belarus, Kazakhstan, and Armenia
18:00-19:00, Monday November 4, 2013
The forum will discuss main directions of the health care reforms in the CIS countries and the ways to make them efficient through implementing HTA. The forum will encourage HTA development and regional and international cooperation in the HTA field to support rational decision making in health care. Presented by ISPOR Russia HTA, Ukraine, Belarus, Armenia, and Kazakhstan Regional Chapters
Moderator: Vitaly V. Omelyanovskiy, MD, PhD, Professor, Director of Center for HTA, Russian Presidential Academy of National Economy & Public Administration, President of ISPOR Russia HTA Chapter   
The event program is available in English and Russian languages.
 
Ways to optimize public funding for drug availability under present conditions
11:45-13:15, Tuesday, November 5, 2013
The meeting will discuss challenges of establishing reimbursement system in Russia, ways to promote innovation in the Russian healthcare sector, recent trends in R&D and reimbursement of innovative technologies as well as value based pricing developments at NICE. 
The meeting will be held in English.
Moderator: Vitaly V. Omelyanovskiy, MD, PhD, Professor, Director of Center for HTA, Russian Presidential Academy of National Economy & Public Administration, President of ISPOR Russia HTA Chapter



ISPOR 15th Annual European Congress
3-7 November 2012
Berlin, Germany
Activities of the Russia HTA Chapter: 
Conjoint_Forum_Agenda_ISPOR_Berlin
Roundtable_HTA of Drugs and Medical Devices
Roundtable_Risk-Sharing in Oncology
* 15 posters were presented


International scientific and practical conference
"International experience in health technology assessment and prospects of its implementation in Russia”


21 May 2012
Moscow, Russia
Conference Program


ISPOR 14th Annual European Congress
5-8 November 2011
Madrid, Spain
Activities of the Russia HTA Chapter: 
* Conjoint Forum of ISPOR Russia HTA Chapter, ISPOR Chapters of Ukraine and Belarus
* Symposium of ISPOR Russia HTA Chapter
* 4 posters were presented


ISPOR 13th Annual European Congress
6-9 November 2010
Prague, Czech Republic
© 2019 Health Technology Assessment in Russia. Send a message         |         Êàðòà ñàéòà         |         Reviewing         |         Ethical rules of the journal         |         Conflict of interests declaration